Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Jones

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Annals of Neurology|December 16, 1998
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene clusterR Feakes, J Chataway, S Sawcer, et al.
Genetic Epidemiology|January 1, 1997
Empirical genomewide significance levels established by whole genome simulationsS Sawcer, H B Jones, D Judge, et al.
Osteoarthritis and Cartilage|December 31, 2008
Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis painK M Clements, A D Ball, H B Jones, et al.
Neurotoxicology|January 1, 1996
Neuropathological changes in rat brain following oral administration of 2-chloropropionic acidM G Simpson, I Wyatt, H B Jones, et al.
Urological Research|January 1, 1994
Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomyH B Jones, G R Betton, A L Bowdler, et al.
Toxicologic Pathology|April 12, 2012
Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differencesM Pinches, C Betts, S Bickerton, et al.
Neuropathology and Applied Neurobiology|July 1, 1984
Evolution of the intracellular changes in neurons caused by trimethyltinA W Brown, J B Cavanagh, R D Verschoyle, et al.
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Current status and future directions for diagnostic markers of drug-induced vascular injuryD A Brott, H B Jones, S Gould, et al.
FEMS Immunology and Medical Microbiology|January 21, 2000
Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor proteinL P Londono, H B Jones, A T Vie, et al.
British Journal of Pharmacology|April 29, 2014
Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetesD J Baker, G P Wilkinson, A M Atkinson, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Annals of Neurology|December 16, 1998
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene clusterR Feakes, J Chataway, S Sawcer, et al.
Genetic Epidemiology|January 1, 1997
Empirical genomewide significance levels established by whole genome simulationsS Sawcer, H B Jones, D Judge, et al.
Osteoarthritis and Cartilage|December 31, 2008
Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis painK M Clements, A D Ball, H B Jones, et al.
Neurotoxicology|January 1, 1996
Neuropathological changes in rat brain following oral administration of 2-chloropropionic acidM G Simpson, I Wyatt, H B Jones, et al.
Urological Research|January 1, 1994
Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomyH B Jones, G R Betton, A L Bowdler, et al.
Toxicologic Pathology|April 12, 2012
Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differencesM Pinches, C Betts, S Bickerton, et al.
Neuropathology and Applied Neurobiology|July 1, 1984
Evolution of the intracellular changes in neurons caused by trimethyltinA W Brown, J B Cavanagh, R D Verschoyle, et al.
Cancer Biomarkers : Section a of Disease Markers|December 29, 2006
Current status and future directions for diagnostic markers of drug-induced vascular injuryD A Brott, H B Jones, S Gould, et al.
FEMS Immunology and Medical Microbiology|January 21, 2000
Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor proteinL P Londono, H B Jones, A T Vie, et al.
British Journal of Pharmacology|April 29, 2014
Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetesD J Baker, G P Wilkinson, A M Atkinson, et al.
Pageof 12